Comparative Outcome Assessment of EGFR TKIs for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis

被引：0
作者：
De Mello, Ramon Andrade [1 ]
Aguiar, Pedro, Jr. [2 ]
Cabral, Paloma [3 ]
Chaves, Fablo [4 ]
Liu, Davi [2 ]
Soares, Joao Paulo [4 ]
Mountzios, Giannis [5 ]
Tadokoro, Hakaru [2 ]
Lopes, Gilberto De Lima [6 ]
机构：
[1] Univ Algarve, Biomed Sci & Med Oncol Div, Faro, Portugal
[2] Univ Fed Sao Paulo, Med Oncol, Sao Paulo, Brazil
[3] Univ Fed Ceara, Med, Fortaleza, Ceara, Brazil
[4] Inst Canc Ceara, Med Oncol, Fortaleza, Ceara, Brazil
[5] Univ Athens, Sch Med, Med Oncol, Athens, Greece
[6] Ctr Paulista Oncol E Hcor Onco, Oncoclin Brasil Grp, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
gefitinib; Erolotinib; afatinib; Non-small-cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-081
引用
收藏
页码：S1239 / S1240
页数：3
相关论文
共 50 条
  • [21] Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis
    Li, Xue
    Wang, Fang
    Jia, Huijun
    Lian, Zhen
    Ren, Kai
    Yuan, Zhiyong
    Wang, Ping
    Zhao, Lujun
    FUTURE ONCOLOGY, 2022, 18 (27) : 3055 - 3065
  • [22] Maintenance Treatment With Different Strategies in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Cai, Haoquan
    Lin, Yingcheng
    Li, Weibing
    Li, Xuyuan
    CLINICAL LUNG CANCER, 2013, 14 (04) : 333 - 341
  • [23] Investigating the Efficacy of EGFR-TKIs and Anti-VEGFR Combination in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
    Sakharkar, Prashant
    Kurup, Sonali
    Deb, Subrata
    Assaad, Kaitlin
    Gesinski, Dayna
    Gayle, Erysa J.
    CANCERS, 2024, 16 (06)
  • [24] Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis
    Wen, Yaokai
    Jiang, Tao
    Wu, Xiangrong
    Peng, Haoxin
    Ren, Shengxiang
    Zhou, Caicun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [25] Network Meta-Analysis of First-Line and Maintenance Regimens in EGFR Mutated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    De Lima Lopes, Gilberto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1224 - S1225
  • [26] Adjuvant EGFR tyrosine kinase inhibitors for patients with resected EGFR-mutated non-small-cell lung cancer: a network meta-analysis
    Tian, Wentao
    Tan, Nuopei
    Ke, Jiawen
    Zou, Ji'an
    Liu, Xiaohan
    Pan, Yue
    Zeng, Yue
    Peng, Yurong
    Wu, Fang
    FUTURE ONCOLOGY, 2022, 18 (21) : 2695 - 2708
  • [27] EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer
    Kao, Hsiang-Fong
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    FUTURE ONCOLOGY, 2013, 9 (07) : 991 - 1003
  • [28] Network meta analysis of first-line therapy for advanced EGFR mutation positive non-small-cell lung cancer: updated overall survival
    Farris, M. S.
    Larkin-Kaiser, K. A.
    Scory, T.
    Boyne, D.
    Wilner, K. D.
    Pastel, M.
    Cappelleri, J. C.
    Ivanova, J. I.
    FUTURE ONCOLOGY, 2020, 16 (36) : 3107 - 3116
  • [29] Impact of Sex and Smoking on the Efficacy of EGFR-TKIs in Terms of Overall Survival in Non-small-Cell Lung Cancer: A Meta-Analysis
    Xiao, Jian
    Zhou, Liang
    He, Bixiu
    Chen, Qiong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [30] EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review
    Chen, Chang-Hung
    Chou, Deng-Wei
    Chung, Kuo-Mou
    Chang, Han-Yu
    MEDICINA-LITHUANIA, 2022, 58 (11):
12345